Tafamidis Meglumine

Spezifikationen

951395-08-7CAS-Nummer

813-716-0EG-Nummer

2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentolIUPAC-Name

C21H24Cl2N2O8Chemische Formel

503.3 g/molMolekulargewicht

Tafamidis meglumine; 951395-08-7; Fx1006A; ZU7CF08A1A; CHEBI:79345; D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)-, 2-(3,5-DICHLOROPHENYL)-6-BENZOXAZOLECARBOXYLATE (1:1); D-GLUCO-2,3,4,5,6-PENTAHYDROXY-N-METHYLHEXAN-1-AMINIUM 2-(3,5-DICHLOROPHENYL)BENZOXAZOLE-6-CARBOXYLATE; RefChem:56086; Vyndaqel; Fx-1006A; (2R,3R,4R,5S)-6-(Methylamino)hexane-1,2,3,4,5-pentaol 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate; Fx 1006A; C21H24Cl2N2O8; 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol; 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid--1-deoxy-1-(methylamino)-D-glucitol (1/1); UNII-ZU7CF08A1A; Tafamidis meglumine [USAN]; Tafamidis meglumine [USAN:INN]; 951395-08-7 (meglumine); Vyndaqel (TN); Tafamidis meglumine?; orb1299686; CHEMBL2105675; SCHEMBL14783506; SCHEMBL29361538; TAFAMIDIS MEGLUMINE [MI]; Tafamidis meglumine (JAN/USAN); DTXSID50915094; TAFAMIDIS MEGLUMINE [JAN]; EX-A3550; EBC-70026; HY-14852A; MFCD28502032; TAFAMIDIS MEGLUMINE [WHO-DD]; AKOS037649321; AT18247; D-Glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate; TAFAMIDIS MEGLUMINE [ORANGE BOOK]; (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic acid; BS-18043; DA-78162; CS-0045567; T7582; PF-06291826; D09674; Q27148396; 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate; 2-(3,5-Dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid--1-deoxy-1-(methylamino)hexitol (1/1); Tafamidis Meglumine MicronizedSynonyme